Description

Nabota 200: Global Quality Standard and Maximum Profitability

Nabota 200 is a premium botulinum toxin type A from Daewoong Pharmaceutical (South Korea), available in an extended dosage format. As one of the rare Korean neurotoxins to achieve both FDA (USA) and EMA (Europe) approvals, it stands as a global benchmark for safety and efficacy. The 200-unit vial is the optimal, cost-effective solution for high-volume clinics and comprehensive treatments, including “full face” rejuvenation protocols, hyperhidrosis therapy, and body contouring procedures.

Key Benefits Nabota 200:

Cost-Effectiveness: The 200-unit vial significantly reduces the cost per unit, making it ideal for extensive protocols and busy aesthetic practices.

International Certification (FDA & EMA): A guarantee of the highest clinical standards, ensuring absolute trust from both practitioners and patients.

HI-PURE Technology: Advanced multi-step purification minimizes the foreign protein load, effectively preventing the development of antibody resistance.

Precision and Speed: The product is characterized by a rapid onset of action (often within 2 days) and minimal diffusion, eliminating the risk of unexpected asymmetry.

Indications:

Comprehensive treatment of localized hyperhidrosis (axillae, palms, soles).

“Full face” dynamic wrinkle correction.

Correction of hypertonicity in larger muscles (platysmal bands, masseter muscle for bruxism).

Body botulinum therapy (e.g., trapezius muscle contouring).

Specifications:

Active Ingredient: Botulinum Toxin Type A (200 Units).

Form: Lyophilized powder (1 vial).

Manufacturer: Daewoong Pharmaceutical (South Korea).